Cidara Therapeutics, Inc. - COM NEW (CDTX)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / COM NEW
Number of holders
40
Total Shares
6.87M
Shares change
+3.57M
Total reported value, excl. options
$184M
Value change
+$101M
Put/Call ratio
0
Number of buys
30
Number of sells
-7
Price
$26.88
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.